Literature DB >> 24519690

Equations for converting scores between depression scales (MÅDRS, SRS, PHQ-9 and BDI-II): good statistical, but weak idiographic, validity.

Chris J Hawley1, Tim M Gale, Paul St John Smith, Sanjay Jain, Ako Farag, Raj Kondan, Cerian Avent, Juliet Graham.   

Abstract

BACKGROUND: A variety of depression rating scales are currently used in clinical and research practice. As these scales are generally thought to correlate well, there may be some benefit in deriving equations to translate the score on one scale to that on another.
METHOD: Using pairwise ratings, we compared the Montgomery-Åsberg Depression Rating Scale (MÅDRS), Beck Depression Inventory II (BDI-II), Patient Health Questionnaire (PHQ-9) and Zung Self Rated Scale (SRS). The primary comparisons of interest were as follows: PHQ-9 and MÅDRS, PHQ-9 and BDI-II, SRS and MÅDRS, and SRS and PHQ-9. One hundred and fifty pairs of ratings were collected for each of these four comparisons, and these were used in a regression analysis to generate a predictive equation between scale pairs. The predictive equations were then tested for accuracy by using novel data.
RESULTS: There was a reasonably strong correlation between scales. Simple regression equations describe the relationships between certain permutations of the BDI-II, PHQ-9, SRS and MÅDRS well enough to allow the score on one scale to be estimated from the score on another. On average, the equations work well. However, when used to predict individual cases, they often fail.
CONCLUSION: It does appear that conversion equations for depression scores are precise enough to be of use when applied to averages; these might aid comparison of data across different studies, meta-analysis or instrument selection for clinical trials. But regarding scale translation at the idiographic level, the variability we have observed is so great that severe doubt is cast on the validity of such an approach.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  BDI; MÅDRS; PHQ; SRS; correlation; depression; equation; rating scale

Mesh:

Year:  2013        PMID: 24519690     DOI: 10.1002/hup.2341

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  7 in total

1.  Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels.

Authors:  Sandra Van der Auwera; Sabine Ameling; Katharina Wittfeld; Enrique d'Harcourt Rowold; Matthias Nauck; Henry Völzke; Karsten Suhre; Hani Najafi-Shoushtari; Jaicy Methew; Vimal Ramachandran; Robin Bülow; Uwe Völker; Hans J Grabe
Journal:  Neuropsychopharmacology       Date:  2019-07-08       Impact factor: 7.853

Review 2.  A systematic review of depression psychotherapies among Latinos.

Authors:  Anahí Collado; Aaron C Lim; Laura MacPherson
Journal:  Clin Psychol Rev       Date:  2016-04-09

3.  Embodying self-compassion within virtual reality and its effects on patients with depression.

Authors:  Caroline J Falconer; Aitor Rovira; John A King; Paul Gilbert; Angus Antley; Pasco Fearon; Neil Ralph; Mel Slater; Chris R Brewin
Journal:  BJPsych Open       Date:  2016-02-15

4.  Internet-Delivered Cognitive Behavioral Therapy for Insomnia Comorbid With Chronic Pain: Randomized Controlled Trial.

Authors:  Tobias Wiklund; Peter Molander; Philip Lindner; Gerhard Andersson; Björn Gerdle; Elena Dragioti
Journal:  J Med Internet Res       Date:  2022-04-29       Impact factor: 7.076

Review 5.  A systematic review of digital and face-to-face cognitive behavioral therapy for depression.

Authors:  Lana Kambeitz-Ilankovic; Uma Rzayeva; Laura Völkel; Julian Wenzel; Johanna Weiske; Frank Jessen; Ulrich Reininghaus; Peter J Uhlhaas; Mario Alvarez-Jimenez; Joseph Kambeitz
Journal:  NPJ Digit Med       Date:  2022-09-15

6.  Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study.

Authors:  Sachin Ahuja; Madeline Brendle; Leo Smart; Claire Moore; Paul Thielking; Reid Robison
Journal:  BMC Psychiatry       Date:  2022-10-03       Impact factor: 4.144

7.  Health-related quality of life and burden of illness in adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden.

Authors:  E Ahnemark; M Di Schiena; A-C Fredman; E Medin; J K Söderling; Y Ginsberg
Journal:  BMC Psychiatry       Date:  2018-07-13       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.